Insider Buying: Cosmos Health Inc. (NASDAQ:COSM) CEO Purchases 354,296 Shares of Stock

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) CEO Grigorios Siokas bought 354,296 shares of Cosmos Health stock in a transaction on Monday, February 24th. The shares were purchased at an average cost of $0.56 per share, for a total transaction of $198,405.76. Following the acquisition, the chief executive officer now owns 3,897,016 shares in the company, valued at $2,182,328.96. The trade was a 10.00 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Grigorios Siokas also recently made the following trade(s):

  • On Thursday, January 30th, Grigorios Siokas bought 51,414 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.66 per share, for a total transaction of $33,933.24.
  • On Wednesday, January 22nd, Grigorios Siokas bought 38,900 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.77 per share, for a total transaction of $29,953.00.
  • On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were purchased at an average cost of $0.86 per share, for a total transaction of $25,075.88.
  • On Wednesday, January 15th, Grigorios Siokas purchased 62,500 shares of Cosmos Health stock. The shares were bought at an average price of $0.80 per share, for a total transaction of $50,000.00.
  • On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
  • On Friday, December 20th, Grigorios Siokas purchased 257,334 shares of Cosmos Health stock. The shares were bought at an average price of $0.58 per share, for a total transaction of $149,253.72.

Cosmos Health Stock Up 4.5 %

Shares of Cosmos Health stock opened at $0.59 on Wednesday. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. The business’s 50 day simple moving average is $0.69 and its 200-day simple moving average is $0.82. The stock has a market capitalization of $13.72 million, a price-to-earnings ratio of -0.24 and a beta of 5.56. Cosmos Health Inc. has a twelve month low of $0.47 and a twelve month high of $1.58.

Institutional Trading of Cosmos Health

An institutional investor recently raised its position in Cosmos Health stock. Geode Capital Management LLC lifted its stake in shares of Cosmos Health Inc. (NASDAQ:COSMFree Report) by 29.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 193,432 shares of the company’s stock after purchasing an additional 43,704 shares during the quarter. Geode Capital Management LLC owned about 0.83% of Cosmos Health worth $129,000 as of its most recent filing with the Securities and Exchange Commission. 12.61% of the stock is currently owned by hedge funds and other institutional investors.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.

Featured Stories

Insider Buying and Selling by Quarter for Cosmos Health (NASDAQ:COSM)

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.